Financials
- Market Capitalization 483.78 M
- Employee 87
- Founded N/A
- CEO N/A
- Website www.editasmedicine.com
- Headquarter Delaware, United States
- FIGI BBG005MX5GZ2
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.14
市销率
4.49
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2890 | ENTX Entera Bio Ltd. - Ordinary Shares | 3.04 USD | -1.30% | -5.88% | -5.59% | +52.00% | 526.35 M USD | ||
| 2894 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.36 USD | -3.24% | -0.71% | +11.47% | +114.36% | 517.01 M USD | ||
| 2942 | EVMN Evommune, Inc. Common Stock | 13.22 USD | -1.56% | -3.36% | +18.99% | -23.67% | 479.78 M USD | ||
| 2947 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.85 USD | -6.10% | -3.75% | +11.59% | +52.17% | 473.65 M USD |